HHS launches Operation Trialblazer to accelerate U.S. drug research amid growing competition from China

The Department of Health and Human Services introduced a new initiative called Operation Trialblazer aimed at speeding early-stage drug research in the United States.

The plan calls for coordinated actions across agencies such as the FDA and NIH to modernize regulations, improve patient access, and use data and technology to streamline the review process.

Experts say the effort is a positive step but caution that faster regulatory timelines alone will not guarantee scientific success; strong trial design remains essential as U.S. trials lag behind China and other countries.